Designation advances the company’s Urine (UTI) ID/AST Panel on Pattern’s single-cell microbiology platform. AUSTIN, Texas, September 21, 2026 — Pattern Bioscience, an innovator in rapid diagnostic technologies for bacterial infections, today announced that the U.S....
Commercial leader in diagnostics joins Pattern to build US sales organization as the company nears FDA submission of its breakthrough single-cell microbiology platform and launch of the Pneumonia ID/AST Panel. AUSTIN, Texas, July 27, 2026 — Pattern Bioscience, an...
